Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Varonis Systems jumps after results; Morgan Stanley positive

Published 02/06/2024, 09:28 PM
Updated 02/06/2024, 09:28 PM
© Reuters.

Shares of Varonis Systems (NASDAQ:VRNS) jumped over 7% on Monday's market pre-open after the software maker posted better-than-anticipated Q4 earnings and revenue.

Earnings per share (EPS) stood at $0.27 in the fourth quarter, exceeding the consensus estimates of $0.23. Revenue came in at $154.1 million, while analysts were expecting $151.83 million.

For the fiscal Q1 2024, Varonis expects a loss per share of $0.10 to $0.09, compared to the loss per share of $0.01 expected by analysts. Revenue is anticipated to land between $111 million and $115 million in that quarter, while analysts guided for $116.4 million.

For the full-year, the software company estimates EPS of $0.11 to $0.13 on revenue of $536 million to $546 million. This compares to EPS of $0.35 and revenue of $544 million projected by analysts.

In the report’s aftermath, TD Cowen analysts hiked the target price on the stock to $54 from $50 and maintained the Outperform rating.

"We are raising our PT on VRNS to $54 from $50 following strong 4Q23 results, headlined by ARR of $543M (vs. St's $537M, up 17% y/y, and powered by robust SaaS adoption,” they said.

“SaaS generated 66% of new business/up-sell and now represents 23% of total ARR. VRNS accelerated its transition timeline by a year. Free cash flow grew sharply y/y to $54M from $0.5M. Reiterate Outperform."

Similarly, Morgan Stanley analysts reiterated the Overweight rating on the stock and hiked the 12-month target price to $60 from $55.

“VRNS reported a solid Q4 with ARR accelerating to +17% YoY and FY24 ARR outlook was ahead of consensus. With growing SaaS momentum and burgeoning GenAI tailwinds, we see room for material upward revisions throughout the year,” they wrote.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.